Review · Current opinion in allergy and clinical immunology · 2021Abstract only

Wheat oral immunotherapy: desensitization and reaction risks

What it found

Wheat oral immunotherapy often desensitizes people with wheat allergy, especially with higher maintenance doses taken for longer.

It can also cause allergic reactions, including anaphylaxis, often when something like exercise is involved.

What they found

Studies in people

Desensitization usually works

Most wheat oral immunotherapy regimens led to successful desensitization in people. Success was more likely when people took higher maintenance doses for longer periods.

Reactions can occur

Wheat oral immunotherapy can cause allergic reactions, including anaphylaxis. More severe reactions often had an augmenting factor such as exercise.

Lower doses, fewer reactions

Lower maintenance doses were likely linked to less severe reactions. Changing the food or adding other treatments may also lower the risk of reactions.

Sustained unresponsiveness unclear

Only a small number of studies have looked at whether people stay desensitized after stopping treatment.

Other findings

Trial limits

The trials were generally small, which affected the mix of patients studied. There was also little standardization of how success and safety were measured, making it hard to compare trials directly.

What the authors conclude

“WOIT trials are ongoing and will optimize updosing protocols and maintenance doses to improve efficacy and safety.”
Leeds S, Liu EG, Nowak-Wegrzyn A, 2021

Also in their conclusions

  • They say wheat oral immunotherapy trials are ongoing and will refine dosing schedules and maintenance doses to improve how well it works and how safe it is.

How it was done

Food allergy is becoming more common worldwide, so more attention is being paid to how specific food allergies are managed.

The authors reviewed human trials of wheat oral immunotherapy, including one multicenter double-blind randomized controlled trial, one randomized noncontrolled trial, and several smaller nonrandomized clinical trials.

What it can’t tell you

  • We summarised it from the abstract only.
  • The trials were small and used different ways to measure success and safety, so it is hard to compare them directly.
  • Only a few studies looked at whether the effect lasts after treatment stops.

The paper

Title
Wheat oral immunotherapy
Type
ReviewThe authors read earlier studies and describe what they found. It isn’t a new study.
Evidence
Studies in people
Summarised from
Abstract only
Cite
Leeds S, Liu EG, Nowak-Wegrzyn A (2021). Wheat oral immunotherapy. Current opinion in allergy and clinical immunology. doi:10.1097/ACI.0000000000000743PubMed 33840798DOI

Summary written 26 Sep 2026. Check it against the paper before it changes what you eat. How we summarise papers · Report an error